| 12486249 |
SSTR4 agonist salts |
David Michael Remick |
2025-12-02 |
|
| 12252491 |
IL-17A inhibitors |
Kwame Frimpong, William Glen Holloway, Brian Spencer Jones, Adam Marc Levinson, Charles Willis Lugar, III +3 more |
2025-03-18 |
|
| 12071423 |
Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-N-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate, and preparation of 2,4,6-trifluoro-N-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide acetate |
Aktham Aburub, Scott Alan Frank, Mark Steven Kerr, Roger Ryan Rothhaar, Radhe Krishan Vaid |
2024-08-27 |
$6,080,344,000 |
| 11999722 |
Disubstituted pyrazole compounds |
Timothy Barrett Durham, Richard Duane Johnston, Steven Marc Massey, Patrick Gianpietro Spinazze, Douglas Richard Stack +1 more |
2024-06-04 |
$5,685,580,000 |
| 11834435 |
SSTR4 agonist salts |
David Michael Remick |
2023-12-05 |
$1,985,610,000 |
| 11827618 |
Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate, and preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide acetate |
Aktham Aburub, Scott Alan Frank, Mark Steven Kerr, Roger Ryan Rothhaar, Radhe Krishan Vaid |
2023-11-28 |
|
| 11746115 |
Solid forms of 7-[[(1S)-1-[4-[(1S)-2-cyclopropyl-1-(4-prop-2-enoylpiperazin-1-yl)ethyl]phenyl]ethyl]amino]-1-ethyl-4H-pyrimido[4,5-d][1,3]oxazin-2-one |
Yizheng Cao |
2023-09-05 |
$2,090,337,000 |
| 11655242 |
Glucagon-like peptide1 receptor agonists |
Todd FIELDS, Joseph Daniel HO, Fucheng Qu |
2023-05-23 |
$1,367,043,000 |
| 11498915 |
TrkA Inhibitor |
Ryan James Linder, Laia Malet-Sanz |
2022-11-15 |
$1,217,543,000 |
| 11490180 |
Electroacoustic driver housing element |
John Robbert Kendrick |
2022-11-01 |
|
| 11124500 |
Disubstituted pyrazole compounds |
Timothy Barrett Durham, Richard Duane Johnston, Steven Marc Massey, Patrick Gianpietro Spinazze, Douglas Richard Stack +1 more |
2021-09-21 |
$354,607,000 |
| 11066386 |
CGRP receptor antagonists |
Simon James Richards, Adam Jan Sanderson |
2021-07-20 |
$606,908,000 |
| 11012785 |
Electroacoustic driver and related loudspeaker/sounder |
— |
2021-05-18 |
|
| 10968214 |
KRas G12C inhibitors |
David Anthony Barda, Ryan James Linder, Sheng-Bin Peng, Mohammad Sadegh Zia-Ebrahimi |
2021-04-06 |
$1,544,764,000 |
| 10934280 |
Condensed thiophene derivatives useful as NaPi-IIb inhibitors |
Kevin Robert Fales, Jeffrey Allen Peterson, Jeffrey Michael Schkeryantz, Quanrong Shen, Matthew John Valli +3 more |
2021-03-02 |
$1,920,729,000 |
| 10793552 |
Amino pyrimidine ssao inhibitors |
Luo Heng Qin, Yi Wei, Jingye Zhou |
2020-10-06 |
$1,143,476,000 |
| 10787460 |
(E)-1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl 4-((3-isopropyl-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)amino)piperidine-1-carboxylate for inhibiting CDK7 |
Carlos Montero, Bharvin Kumar Patel, David Michael Remick, Yipin Yadav |
2020-09-29 |
$1,026,299,000 |
| 10611751 |
Dopamine D1 receptor positive allosteric modulators |
Darryl Wayne Hilliard, Junliang HAO |
2020-04-07 |
$806,252,000 |
| 10464928 |
Amino pyrimidine SSAO inhibitors |
Luo Heng Qin, Yi Wei, Jingye Zhou |
2019-11-05 |
$553,957,000 |
| 10323019 |
Pyrazolylaminobenzimidazole derivatives as JAK inhibitors |
Jolie Anne Bastian, Joshua Clayton, Daniel Jon Sall, Timothy Andrew Woods |
2019-06-18 |
$560,196,000 |
| 10287270 |
Amino pyrimidine SSAO inhibitors |
Luo Heng Qin, Yi Wei, Jingye Zhou |
2019-05-14 |
$292,361,000 |
| 10080758 |
Tosylate salt of N-[3-[(4aR,7aS)-2-amino-6-(5-fluoropyrimidin-2-yl)-4,4a,5,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-7a-yl]-4-fluoro-phenyl]-5-methoxy-pyrazine-2-carboxamide |
Craig Daniel Wolfangel |
2018-09-25 |
$211,775,000 |
| 9920056 |
2-oxo-1,3,8-triazaspiro[4.5]decan-3-yl] carboxylic acid derivatives |
Thomas Beauchamp, Maria Angeles Martinez-Grau, Miguel Angel Toledo |
2018-03-20 |
$313,191,000 |
| 9828390 |
Tetrahydropyrrolo[3,4-D][1,3]thiazine-derivative as BACE inhibitor |
Pablo Garcia Losada |
2017-11-28 |
$348,873,000 |
| 9708297 |
CGRP receptor antagonists |
Kevin Charles FORTNER, Steven Marc Massey, Jason K. Myers, Antonio Navarro, Miles Goodman Siegel +1 more |
2017-07-18 |
$148,447,000 |
